Medox Remedies Private Limited logo

Medox Remedies Private Limited

Produces various pharmaceutical products and partners with well-known healthcare institutions.
2017 | Delhi (India) | Active

Last Updated:

December 17, 2024
HomeCompanyMedox Remedies Private Limited

Who are the key members and board of directors at Medox Remedies?

Board Members(3)

NameDesignationAppointment DateStatus
Narendra Prasad In Director 28-Feb-2017Current
Omprakash Kushwaha In Director 28-Apr-2018Current
Pratibha Dubey In Director 11-Jan-2021Current

Financial Performance of Medox Remedies.

Medox Remedies Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 29.67% increase. The company also saw a substantial fall in profitability, with a 6340.45% decrease in profit. The company's net worth observed a substantial decline by a decrease of 142.06%.

Revenue Growth Graph
Profit Loss Graph
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metric
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
29.67%
Revenue from Operations
29.49%
Total Assets
6.31%
Profit or Loss
-6340.45%
Net Worth
-142.06%
EBITDA
-275.76%

Related Corporates (Common Directorship)

Charges (Loans)

Charges

There are no open charges registered against the company as per our records.

How Many Employees Work at Medox Remedies?

Unlock and access historical data on people associated with Medox Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Graph

Deals i

Rating

Alerts

Latest Updates, News, and FAQs on Medox Remedies

Recent activity within the organization

  • Annual General Meeting

    Medox Remedies Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.

    30 Sep 2022

  • Balance Sheet

    Medox Remedies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Delhi.

    31 Mar 2022

  • Director Appointment

    Pratibha Dubey was appointed as a Director was appointed as a Director on 11 Jan 2021 & has been associated with this company since 4 years 5 days .

    11 Jan 2021

  • Director Appointment

    Omprakash Kushwaha was appointed as a Director was appointed as a Director on 28 Apr 2018 & has been associated with this company since 6 years 8 months .

    28 Apr 2018

  • Director Appointment

    Narendra Kumar Prasad was appointed as a Director was appointed as a Director on 28 Feb 2017 & has been associated with this company since 7 years 10 months .

    28 Feb 2017

  • Company Incorporation

    Medox Remedies Private Limited was registered on 28 Feb 2017 with Roc Delhi & aged 7 years 10 months as per MCA records.

    28 Feb 2017

Frequently asked questions

  • Medox Remedies Private Limited was incorporated on 28 Feb 2017.

  • The authorized share capital of Medox Remedies Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.

  • Currently 3 directors are associated with Medox Remedies Private Limited.

    • Narendra Kumar Prasad
    • Omprakash Kushwaha
    • Pratibha Dubey
  • As per Ministry of Corporate Affairs (Mca), the registered address of Medox Remedies Private Limited is Shop No 3 G/F Prop. No. 920-921, Ward 7 Mehrauli India, New Delhi, 110030.

  • The corporate identification number (CIN) of Medox Remedies Private Limited is U74999DL2017PTC313566 and the company number is 313566 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Medox Remedies Private Limited is https://www.medoxremedies.com

  • According to the financial reports for the fiscal year 2022, the revenue trend for Medox Remedies Private Limited has risen by 29.67%.

  • The financial reports for the fiscal year 2022 indicates that The net worth of Medox Remedies Private Limited has experienced an downturn of -142.06%.

  • The most recent Balance Sheet for Medox Remedies Private Limited was filed with the ROC on 31 Mar 2022.

People also Viewed

Similar Companies Based on Drug Formulation & Development